The Post-Surgical Pain market report provides current treatment practices, emerging drugs, Post-Surgical Pain market share of the individual therapies, current and forecasted Post-Surgical Pain market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Post-Surgical Pain treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Post-Surgical Pain Drugs covered
- Olinvo (Oliceridine injection or TRV130)
- HTX011
- CR845/Difelikefalin
- NTM001
- PF05089771
And many others
The key players in Post-Surgical Pain market are:
- Trevena
- Heron Therapeutics
- Cara Therapeutics
- Neumentum Pharmaceuticals
- Pfizer
And many others
View Report: https://www.delveinsight.com/report-store/post-surgical-pain-market
Idiopathic Membranous Nephropathy Market
The Idiopathic Membranous Nephropathy market report provides current treatment practices, emerging drugs, Idiopathic Membranous Nephropathy market share of the individual therapies, current and forecasted Idiopathic Membranous Nephropathy market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Idiopathic Membranous Nephropathy treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Idiopathic Membranous Nephropathy Drugs covered
- Olinvo (Oliceridine injection or TRV130)
- HTX011
- CR845/Difelikefalin
- NTM001
- PF05089771
And many others
The key players in Idiopathic Membranous Nephropathy market are:
- Trevena
- Heron Therapeutics
- Cara Therapeutics
- Neumentum Pharmaceuticals
- Pfizer
And many others
View Report: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-market
Post Menopausal Osteoporosis Market
The Post Menopausal Osteoporosis market report provides current treatment practices, emerging drugs, Post Menopausal Osteoporosis market share of the individual therapies, current and forecasted Post Menopausal Osteoporosis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Post Menopausal Osteoporosis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
The key players in Post Menopausal Osteoporosis market are:
- Trevena
- Heron Therapeutics
- Cara Therapeutics
- Neumentum Pharmaceuticals
- Pfizer
And many others
View Report: https://www.delveinsight.com/report-store/post-menopausal-osteoporosis-market
Atrial Flutter Market: Trends and Opportunities
Increase in the number of people with various common diseases like obesity and diabetes are anticipated to fuel the world market for atrial flutter over the period of forecast. Rise in the prevalence of many different types of heart diseases like stroke, heart attack, and congestive heart failure are also anticipated to propel the said market. In accordance with the World Health Organization, cardiovascular diseases have been the leading cause of death across the globe. More people die every year from cardiovascular diseases than from any other type of disease. Cardiovascular diseases have been responsible for around 17.7 million deaths in the year 2015, thereby representing around 31% of the total deaths across the globe. Out of all of these deaths, around 7.4 million were owing to coronary heart disease and 6.7 million owing to stroke.
View Report: https://www.delveinsight.com/report-store/atrial-flutter-market
Xerostomia is defined as the “complaint of oral dryness”. It can occur due to inadequate salivary secretion secondary to abnormal function of the salivary glands, which is categorized as “true” xerostomia; however, most patients with xerostomia often do not have objective signs of hypo salivation. “Symptomatic” xerostomia or “pseudo” xerostomia refers to oral dryness despite normal salivary gland function.
Patients with xerostomia can have clinical manifestations of difficulty in swallowing, chewing, and/orspeaking and can present with burning mouth, halitosis, altered taste, dry buccal mucosa, glossitis, cracked and peeled lips, oral candidiasis, and dental caries despite good oral hygiene.
The causes of xerostomia may be divided into two broad categories: systemic diseases and local factors.
Systemic diseases that can cause xerostomia include, but are not limited to, endocrine, autoimmune, infectious, and granulomatous diseases. The more common systemic diseases are reviewed here. Local factors that can cause xerostomia include medications, head and neck radiation therapy, and lifestyle factors.
Xerostomia occurs in 5.5% to 46% of the population, and most commonly in older adults.
View Report: https://www.delveinsight.com/report-store/xerostomia-market